FDA Hunting For Ways To Expand Patient Role In Drug Development
This article was originally published in The Pink Sheet Daily
Agency’s Patient Network Annual Meeting will help explain the drug development process along with agency and patient roles as part of ongoing effort to increase patient involvement.
You may also be interested in...
FDA Breast Cancer Patient Meeting Likely To Examine Differences Between Early Stage And Metastatic Experiences
In April, FDA’s patient focused drug development initiative will look at one of the most emotionally and politically fraught areas of advocacy: breast cancer. Here’s a look at what the agency is likely to hear.
Sen. Bennet is receiving letters from patients asking to talk with FDA about products they think could be a breakthrough.
Sequester Travel: Halved FDA Budget Limits Opportunities For Scientists, Impacts Senior Officials Too
Analysis of meetings in FDA’s public calendar indicates Commissioner Hamburg, other senior leaders continue to attend meetings throughout the U.S. and overseas; stakeholders worry sequester-induced travel cuts prevent rank-and-file scientists from attending helpful events.